Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Coverage of overdose prevention programs for opiate users and injectors, A cross-sectional study

  • Arribas-Ibar, Elisabet
  • Sanchez-Niubo, Albert|||0000-0003-0309-181X
  • Majó, Xavier|||0000-0003-4338-6014
  • Domingo Salvany, Antònia|||0000-0003-3302-4538
  • Brugal, María Teresa|||0000-0003-0580-676X
Background: The use of opiates, particularly heroin, remains an important cause of morbidity and mortality. Half of the deaths among heroin consumers are attributed to overdose. In response to this problem, overdose prevention programs (OPPs) were designed. The objective of our study was to assess coverage of OPPs among the target population in a specific Spanish region (Catalonia) and to identify characteristics related to attendance. Methods: A cross-sectional survey recruited individuals from outpatient treatment centers (OTCs), therapeutic communities (ThCs), and harm reduction facilities (HRFs) in Catalonia. From 513 participants, 306 opiate users and/ or injectors were selected for this study. Coverage was calculated as the proportion of subjects who declared having participated in an OPP. A Poisson regression with robust variance was used to assess factors (socio-demographic aspects and psychoactive substance use patterns) associated to OPP participation, taking into account recruitment strategy. Results: Average age of the 306 subjects was 39.7 years (s.d.: 7.7); 79% were male; 79.2% lived in urban areas and 56.3% were unemployed or had never worked. Overall OPP coverage was 43.5% (95% CI: 37%-49%). Training was received mostly in HRF (60%), followed by OTC (24.4%), prison (19%), and ThC (16%). OPP sessions were attended by 41% of Spanish-born study participants and by 63.3% of foreigners; 92.2% of the participants lived in urban areas. The Poisson regression analysis adjusted by age, sex, and type of recruitment center showed that OPP participation rates were higher for individuals with foreign nationality (PR = 1.3; 95% CI: 1.04-1.72), for those living in municipalities with more than 100,000 inhabitants (PR = 2.0; 95% CI: 1.37-2.81) or the Barcelona conurbation (PR = 2.5; 95% CI: 1.68-3.77), and for those having ever been in prison (PR = 1.6; 95% CI: 1.41-1.81) and had first consumption when they were less than 12 years old (PR = 1.2; 95% CI: 1.06-1.45). Conclusion: Coverage as a whole can be considered high. However, in Catalonia, new strategies ought to be developed in order to attract opiate users and injectors not currently participating, by expanding OPP offer to services and regions where coverage is poor.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Dopamine DRD2/ANKK1 Taq1A and DAT1 VNTR polymorphisms are associated with a cognitive flexibility profile in pathological gamblers

  • Fagundo, Ana Beatriz|||0000-0003-1703-9457
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
  • Torre, Rafael de la|||0000-0002-6765-1866
  • Verdejo-Garcia, Antonio|||0000-0001-8874-9339
  • Granero, Roser|||0000-0001-6308-3198
  • Penelo Werner, Eva|||0000-0001-6796-7660
  • Gené Badia, Manel
  • Barrot, Carme|||0000-0002-3141-4092
  • Sánchez, Cristina
  • Alvarez Moya, Eva Maria|||0000-0002-3723-3225
  • Ochoa, Cristian|||0000-0002-4508-0951
  • Aymamí, Neus|||0000-0002-4607-9565
  • Gomez-Peña, Monica|||0000-0001-6194-8266
  • Menchón Magriñá, José Manuel|||0000-0002-6231-6524
  • Jiménez Murcia, Susana|||0000-0002-3596-8033
Like drug addiction, pathological gambling (PG) has been associated with impairments in executive functions and alterations in dopaminergic functioning; however, the role of dopamine (DA) in the executive profile of PG remains unclear. The aim of this study was to identify whether the DRD2/ANKK1 Taq1Ars1800497 and the DAT1-40 bp VNTR polymorphisms are associated with cognitive flexibility (measured by Wisconsin Card Sorting Test (WCST) and Trail Making Test (TMT)) and inhibition response (measured by Stroop Color and Word Test (SCWT)), in a clinical sample of 69 PG patients. Our results showed an association between DA functioning and cognitive flexibility performance. The Taq1A A1+ (A1A2/A1A1) genotype was associated with poorer TMT performance (p < 0.05), while DAT1 9-repeat homozygotes displayed better WCST performance (p < 0.05) than either 10-repeat homozygotes or heterozygotes. We did not find any association between the DRD2 or DAT1 polymorphisms and the inhibition response. These results suggested that pathological gamblers with genetic predispositions toward lower availability of DA and D2 receptor density are at a higher risk of cognitive flexibility difficulties. Future studies should aim to shed more light on the genetic mechanisms underlying the executive profile in PG.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A new cognitive evaluation battery for Down syndrome and its relevance for clinical trials

  • Sola, Susana de
  • Torre, Rafael de la|||0000-0002-6765-1866
  • Sánchez Benavides, Gonzalo
  • Benejam, Bessy|||0000-0002-6789-8615
  • Cuenca-Royo, Aida|||0000-0001-8551-5457
  • Hoyo Soriano, Laura del|||0000-0003-4372-1599
  • Rodríguez, Joan
  • Catuara-Solarz, Silvina
  • Sánchez-Gutiérrez, Judit
  • Dueñas-Espin, Ivan
  • Hernandez, Gimena|||0000-0001-5319-3465
  • Peña-Casanova, J. (Jordi)|||0000-0003-1019-1536
  • Langohr, Klaus|||0000-0001-7075-9192
  • Videla, Sebastián|||0000-0001-5049-1379
  • Blehaut, Henry
  • Farré Albaladejo, Magí|||0000-0001-8338-7543
  • Dierssen, Mara|||0000-0003-0853-6865
Abstract: The recent prospect of pharmaceutical interventions for cognitive impairment of Down syndrome (DS) has boosted a number of clinical trials in this population. However, running the trials has raised some methodological challenges and questioned the prevailing methodology used to evaluate cognitive functioning of DS individuals. This is usually achieved by comparing DS individuals to matched healthy controls of the same mental age. We propose a new tool, the TESDAD Battery that uses comparison with age-matched typically developed adults. This is an advantageous method for probing the clinical efficacy of DS therapies, allowing the interpretation and prediction of functional outcomes in clinical trials. In our DS population the TESDAD battery permitted a quantitative assessment of cognitive defects, which indicated language dysfunction and deficits in executive function, as the most important contributors to other cognitive and adaptive behavior outcomes as predictors of functional change in DS. Concretely, auditory comprehension and functional academics showed the highest potential as end-point measures of therapeutic intervention for clinical trials: the former as a cognitive key target for therapeutic intervention, and the latter as a primary functional outcome measure of clinical efficacy. Our results also emphasize the need to explore the modulating effects of IQ, gender and age on cognitive enhancing treatments. Noticeably, women performed significantly better than men of the same age and IQ in most cognitive tests, with the most consistent differences occurring in memory and executive functioning and negative trends rarely emerged on quality of life linked to the effect of age after adjusting for IQ and gender. In sum, the TESDAD battery is a useful neurocognitive tool for probing the clinical efficacy of experimental therapies in interventional studies in the DS population suggesting that age-matched controls are advantageous for determining normalization of DS.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

VNTR-DAT1 and COMTVal158Met Genotypes Modulate Mental Flexibility and Adaptive Behavior Skills in Down Syndrome

  • Hoyo Soriano, Laura del|||0000-0003-4372-1599
  • Xicota, Laura|||0000-0003-2832-9214
  • Langohr, Klaus|||0000-0001-7075-9192
  • Sánchez Benavides, Gonzalo
  • de Sola, Susana
  • Cuenca-Royo, Aida|||0000-0001-8551-5457
  • Rodríguez Soler, Joan|||0000-0003-0062-6401
  • Rodríguez-Morató, Jose|||0000-0002-8133-9983
  • Farré Albaladejo, Magí|||0000-0001-8338-7543
  • Dierssen, Mara|||0000-0003-0853-6865
  • Torre, Rafael de la|||0000-0002-6765-1866
Down syndrome (DS) is an aneuploidy syndrome that is caused by trisomy for human chromosome 21 resulting in a characteristic cognitive and behavioral phenotype, which includes executive functioning and adaptive behavior difficulties possibly due to prefrontal cortex (PFC) deficits. DS also present a high risk for early onset of Alzheimer Disease-like dementia. The dopamine (DA) system plays a neuromodulatory role in the activity of the PFC. Several studies have implicated trait differences in DA signaling on executive functioning based on genetic polymorphisms in the genes encoding for the catechol-O-methyltransferase (COMTVal158Met) and the dopamine transporter (VNTR-DAT1). Since it is known that the phenotypic consequences of genetic variants are modulated by the genetic background in which they occur, we here explore whether these polymorphisms variants interact with the trisomic genetic background to influence gene expression, and how this in turn mediates DS phenotype variability regarding PFC cognition. We genotyped 69 young adults of both genders with DS, and found that VNTR-DAT1 was in Hardy-Weinberg equilibrium but COMTVal158Met had a reduced frequency of Met allele homozygotes. In our population, genotypes conferring higher DA availability, such as Met allele carriers and VNTR-DAT1 10-repeat allele homozygotes, resulted in improved performance in executive function tasks that require mental flexibility. Met allele carriers showed worse adaptive social skills and self-direction, and increased scores in the social subscale of the Dementia Questionnaire for People with Intellectual Disabilities than Val allele homozygotes. The VNTR-DAT1 was not involved in adaptive behavior or early dementia symptoms. Our results suggest that genetic variants of COMTVal158Met and VNTR-DAT1 may contribute to PFC-dependent cognition, while only COMTVal158Met is involved in behavioral phenotypes of DS, similar to euploid population.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Cross sectional study of factors associated to self-reported blood-borne infections among drug users

  • Reyes-Urueña, Juliana|||0000-0002-3122-6518
  • Brugal, María Teresa|||0000-0003-0580-676X
  • Majo, Xavier
  • Domingo Salvany, Antònia|||0000-0003-3302-4538
  • Caylà, Joan A.|||0000-0003-3891-111X
The study's aim was to estimate the self-reported prevalence of Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV), and to describe their associated risk factors in a population of users of illicit drugs recruited in Catalonia- Spain, during 2012. Cross-sectional study. People with illicit drugs use were selected in three different types of healthcare centres. The questionnaire was a piloted, structured ad hoc instrument. An analysis was made to identify factors associated to self-reported HCV, HIV and co-infection. Correlates of reported infections were determined using univariate and multivariate Poisson regression (with robust variance). Among 512 participants, 39.65 % self-reported positive serostatus for HCV and 14.84 % for HIV, co-infection was reported by 13.48 %. Among the 224 injecting drug users (IDUs), 187 (83.48 %), 68 (30.36 %) and 66 (29.46 %) reported being positive for HCV, HIV and co-infection, respectively. A higher proportion of HIV-infected cases was observed among women, (18.33 % vs. 13.78 % in men). Prevalence of HCV, HIV and co-infection were higher among participants with early onset of drug consumption, long periods of drug injection or who were unemployed. A positive serostatus was self-reported by 21(7.34 %) participants who did not report any injection; among them 16 and eight, reported being positive for HCV and HIV, respectively; three reported co-infection. Only two people declared exchanging sex for money. For those that reported a negative test, the median time since the last HIV test was 11.41 months (inter-quartile range (IQR) 4-12) and for the HCV test was 4.5 months (IQR 2-7). Among drug users in Catalonia, HIV, HCV and co-infection prevalence are still a big issue especially among IDUs. Women and drug users who have never injected drugs are groups with a significant risk of infection; this might be related to their high-risk behaviours and to being unaware of their serological status.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Moderate-Vigorous Physical Activity across Body Mass Index in Females, Moderating Effect of Endocannabinoids and Temperament

  • Fernández Aranda, Fernando|||0000-0002-2968-9898
  • Sauchelli, Sarah|||0000-0003-3620-7671
  • Pastor, Antoni|||0000-0003-3692-0696
  • González, Marcela L.|||0000-0002-2293-4109
  • Torre, Rafael de la|||0000-0002-6765-1866
  • Granero, Roser|||0000-0001-6308-3198
  • Jiménez Murcia, Susana|||0000-0002-3596-8033
  • Baños, Rosa|||0000-0003-0626-7665
  • Botella, Cristina|||0000-0001-8783-6959
  • Fernández-Real Lemos, José Manuel|||0000-0002-7442-9323
  • Fernández-García, José C.|||0000-0003-2229-8488
  • Frühbeck, Gema|||0000-0002-8305-7154
  • Gómez-Ambrosi, Javier|||0000-0001-5601-1604
  • Rodríguez, Roser
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Arcelus, Jon|||0000-0002-3805-0180
  • Fagundo, Ana Beatriz|||0000-0003-1703-9457
  • Agüera, Zaida|||0000-0003-4453-4939
  • Miró, Jordi|||0000-0002-1085-0039
  • Casanueva, Felipe F.|||0000-0002-9052-8161
Endocannabinoids and temperament traits have been linked to both physical activity and body mass index (BMI) however no study has explored how these factors interact in females. The aims of this cross-sectional study were to 1) examine differences among distinct BMI groups on daytime physical activity and time spent in moderate-vigorous physical activity (MVPA), temperament traits and plasma endocannabinoid concentrations; and 2) explore the association and interaction between MVPA, temperament, endocannabinoids and BMI. Physical activity was measured with the wrist-worn accelerometer Actiwatch AW7, in a sample of 189 female participants (43 morbid obese, 30 obese, and 116 healthy-weight controls). The Temperament and Character Inventory-Revised questionnaire was used to assess personality traits. BMI was calculated by bioelectrical impedance analysis via the TANITA digital scale. Blood analyses were conducted to measure levels of endocannabinoids and endocannabinoid-related compounds. Path-analysis was performed to examine the association between predictive variables and MVPA. Obese groups showed lower MVPA and dysfunctional temperament traits compared to healthy-weight controls. Plasma concentrations of 2-arachidonoylglyceryl (2-AG) were greater in obese groups. Path-analysis identified a direct effect between greater MVPA and low BMI (b = -0.13, p = .039) and high MVPA levels were associated with elevated anandamide (AEA) levels (b = 0.16, p = .049) and N -oleylethanolamide (OEA) levels (b = 0.22, p = .004), as well as high Novelty seeking (b = 0.18, p <.001) and low Harm avoidance (b = -0.16, p <.001). Obese individuals showed a distinct temperament profile and circulating endocannabinoids compared to controls. Temperament and endocannabinoids may act as moderators of the low MVPA in obesity.